Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00998946   Information provided by Spectrum Pharmaceuticals, Inc

First Received on October 19, 2009.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma, B-Cell
Additional conditions recognized in this trial
Lymphoma
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Pralatrexate Injection
Vitamin B12
Folic Acid
Additional drug interventions recognized in this trial
10-deazaaminopterin
Aminopterin
Hydroxocobalamin
Vitamin B 12
Vitamin B Complex
Vitamins
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Growth Substances
Hematinics
Hematologic Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Spectrum Pharmaceuticals, Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services